{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:15:02Z","timestamp":1781594102094,"version":"3.54.5"},"reference-count":84,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T00:00:00Z","timestamp":1503964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3D0651"],"award-info":[{"award-number":["CMRPG3D0651"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3E2001"],"award-info":[{"award-number":["CMRPG3E2001"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology of Taiwan","doi-asserted-by":"publisher","award":["104-2314-B-182\u2009A-114-MY3"],"award-info":[{"award-number":["104-2314-B-182\u2009A-114-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000291","name":"Kidney Research UK","doi-asserted-by":"publisher","award":["RP4\/2014"],"award-info":[{"award-number":["RP4\/2014"]}],"id":[{"id":"10.13039\/501100000291","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sheffield Kidney Research Foundation"},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["EU-FP7\/2007\u20132013"],"award-info":[{"award-number":["EU-FP7\/2007\u20132013"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["317246"],"award-info":[{"award-number":["317246"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.1093\/ndt\/gfx262","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T11:14:06Z","timestamp":1500981246000},"page":"1310-1316","source":"Crossref","is-referenced-by-count":29,"title":["Targeting new cellular disease pathways in autosomal dominant polycystic kidney disease"],"prefix":"10.1093","volume":"33","author":[{"given":"Ming-Yang","family":"Chang","sequence":"first","affiliation":[{"name":"Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"C.M. Ong","sequence":"additional","affiliation":[{"name":"Kidney Genetics Group, Academic Nephrology Unit, University of Sheffield Medical School, Sheffield, UK"},{"name":"Sheffield Kidney Institute, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,8,29]]},"reference":[{"key":"key\n\t\t\t\t20180801040003_gfx262-B1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrneph.2010.18","article-title":"Molecular diagnostics for autosomal dominant polycystic kidney disease","volume":"6","author":"Harris","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B2","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1681\/ASN.2013111184","article-title":"Predictors of autosomal dominant polycystic kidney disease progression","volume":"25","author":"Schrier","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ki.2015.207","article-title":"A polycystin-centric view of cyst formation and disease: the polycystins revisited","volume":"88","author":"Ong","year":"2015","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B4","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/S0140-6736(17)30928-5","article-title":"Making sense of polycystic kidney disease","volume":"389","author":"Ong","year":"2017","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B5","doi-asserted-by":"crossref","first-page":"c25\u2013c34","DOI":"10.1159\/000334166","article-title":"Mechanism-based therapeutics for autosomal dominant polycystic kidney disease: recent progress and future prospects","volume":"120","author":"Chang","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ng1076","article-title":"Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells","volume":"33","author":"Nauli","year":"2003","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B7","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1172\/JCI72272","article-title":"Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease","volume":"124","author":"Harris","year":"2014","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B8","first-page":"195","article-title":"Molecular pathways and therapies in autosomal-dominant polycystic kidney disease","volume":"30","author":"Saigusa","year":"2015","journal-title":"Physiol (Bethesda)"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","article-title":"Autosomal dominant polycystic kidney disease: the last 3\u2009years","volume":"76","author":"Torres","year":"2009","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000112495","article-title":"Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and treatment","volume":"108","author":"Chang","year":"2008","journal-title":"Nephron Physiol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B11","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.bbadis.2011.01.011","article-title":"Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease","volume":"1812","author":"Terryn","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B12","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.bbadis.2011.03.003","article-title":"Polycystins, focal adhesions and extracellular matrix interactions","volume":"1812","author":"Drummond","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B13","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.1073\/pnas.0408518102","article-title":"Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease","volume":"102","author":"Tao","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrneph.2014.137","article-title":"Translational research in ADPKD: lessons from animal models","volume":"10","author":"Happe","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B15","doi-asserted-by":"crossref","first-page":"F1193","DOI":"10.1152\/ajprenal.00419.2010","article-title":"Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model","volume":"300","author":"Leonhard","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B16","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1681\/ASN.2010010127","article-title":"Aberrant regulation of planar cell polarity in polycystic kidney disease","volume":"21","author":"Luyten","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B17","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nm.2171","article-title":"Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models","volume":"16","author":"Natoli","year":"2010","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B18","doi-asserted-by":"crossref","first-page":"C522","DOI":"10.1152\/ajpcell.00163.2010","article-title":"c-Src inactivation reduces renal epithelial cell-matrix adhesion, proliferation, and cyst formation","volume":"301","author":"Elliott","year":"2011","journal-title":"Am J Physiol Cell Physiol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B19","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.bbadis.2010.10.008","article-title":"Epigenetics and autosomal dominant polycystic kidney disease","volume":"1812","author":"Li","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B20","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/bcp.12136","article-title":"New treatments for autosomal dominant polycystic kidney disease","volume":"76","author":"Chang","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B21","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ndt\/gfv456","article-title":"Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice","volume":"31","author":"Gansevoort","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B23","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.12688\/f1000research.9045.1","article-title":"Autosomal dominant polycystic kidney disease: recent advances in clinical management","volume":"5","author":"Mao","year":"2016","journal-title":"F1000Res"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B24","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(15)60907-2","article-title":"Autosomal dominant polycystic kidney disease: the changing face of clinical management","volume":"385","author":"Ong","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B25","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1053\/j.ajkd.2016.07.023","article-title":"Low-osmolar diet and adjusted water intake for vasopressin reduction in autosomal dominant polycystic kidney disease: a pilot randomized controlled trial","volume":"68","author":"Amro","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2215\/CJN.03950510","article-title":"Water prescription in autosomal dominant polycystic kidney disease: a pilot study","volume":"6","author":"Wang","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B27","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nm1783","article-title":"A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease","volume":"14","author":"Li","year":"2008","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B28","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1172\/JCI80467","article-title":"Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease","volume":"125","author":"Chen","year":"2015","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B29","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/ndt\/gfw058","article-title":"Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor kappaB-induced inflammation","volume":"31","author":"Wu","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B30","doi-asserted-by":"crossref","first-page":"21819","DOI":"10.1073\/pnas.0911987106","article-title":"Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models","volume":"106","author":"Cao","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B31","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1093\/hmg\/ddv136","article-title":"Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD","volume":"24","author":"Zhou","year":"2015","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B32","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0140-6736(13)61407-5","article-title":"Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial","volume":"382","author":"Caroli","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B33","doi-asserted-by":"crossref","first-page":"C522","DOI":"10.1152\/ajpcell.00163.2010","article-title":"c-Src inactivation reduces renal epithelial cell-matrix adhesion, proliferation, and cyst formation","volume":"301","author":"Elliott","year":"2011","journal-title":"Am J Physiol-Cell Physiol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B34","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1681\/ASN.2007060665","article-title":"Src inhibition ameliorates polycystic kidney disease","volume":"19","author":"Sweeney","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B35","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B36","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.2015020132","article-title":"Food restriction ameliorates the development of polycystic kidney disease","volume":"27","author":"Warner","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B37","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.mehy.2009.05.043","article-title":"Activation of AMP-activated kinase as a strategy for managing autosomal dominant polycystic kidney disease","volume":"73","author":"McCarty","year":"2009","journal-title":"Med Hypotheses"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B38","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/ndt\/gft521","article-title":"Defective metabolism in polycystic kidney disease: potential for therapy and open questions","volume":"29","author":"Rowe","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B39","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1681\/ASN.2015030231","article-title":"2-Deoxy-d-glucose ameliorates PKD progression","volume":"27","author":"Chiaravalli","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B40","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1073\/pnas.1011498108","article-title":"Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis","volume":"108","author":"Takiar","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B41","doi-asserted-by":"crossref","first-page":"e1003053","DOI":"10.1371\/journal.pgen.1003053","article-title":"Network analysis of a Pkd1-mouse model of autosomal dominant polycystic kidney disease identifies HNF4alpha as a disease modifier","volume":"8","author":"Menezes","year":"2012","journal-title":"PLoS Genet"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B42","first-page":"183","article-title":"Fatty acid oxidation is impaired in an orthologous mouse model of autosomal dominant polycystic kidney disease","volume":"5","author":"Menezes","year":"2016","journal-title":"EBio Med"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B43","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","article-title":"Autophagy as a regulated pathway of cellular degradation","volume":"290","author":"Klionsky","year":"2000","journal-title":"Science"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B44","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1158\/1078-0432.CCR-15-0490","article-title":"Autophagy, metabolism, and cancer","volume":"21","author":"White","year":"2015","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B45","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.4161\/auto.19821","article-title":"Emerging role of autophagy in kidney function, diseases and aging","volume":"8","author":"Huber","year":"2012","journal-title":"Autophagy"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B46","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.kint.2016.04.014","article-title":"Autophagy in kidney disease and aging: lessons from rodent models","volume":"90","author":"Lenoir","year":"2016","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B47","doi-asserted-by":"crossref","first-page":"F1235","DOI":"10.1152\/ajprenal.00348.2010","article-title":"Hypoxia-inducible factor-1alpha (HIF-1alpha) and autophagy in polycystic kidney disease (PKD)","volume":"300","author":"Belibi","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B48","first-page":"158","article-title":"Autophagy activators suppress cystogenesis in an autosomal dominant polycystic kidney disease model","volume":"26","author":"Zhu","year":"2017","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B49","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1172\/JCI73941","article-title":"The role for autophagy in cancer","volume":"125","author":"White","year":"2015","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceb.2016.01.008","article-title":"Autophagy and primary cilia: dual interplay","volume":"39","author":"Pampliega","year":"2016","journal-title":"Curr Opin Cell Biol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B51","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/ncb3360","article-title":"Primary-cilium-dependent autophagy controls epithelial cell volume in response to fluid flow","volume":"18","author":"Orhon","year":"2016","journal-title":"Nat Cell Biol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B52","doi-asserted-by":"crossref","first-page":"e73173","DOI":"10.1371\/journal.pone.0073173","article-title":"The role of phospholipase D in modulating the MTOR signaling pathway in polycystic kidney disease","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B53","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2215\/CJN.04140510","article-title":"Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease","volume":"6","author":"Menon","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B54","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1194\/jlr.P042176","article-title":"Bioactive lipid mediators in polycystic kidney disease","volume":"55","author":"Klawitter","year":"2013","journal-title":"J Lipid Res"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B55","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1093\/ndt\/gfl071","article-title":"Gene profiling of polycystic kidneys","volume":"21","author":"Schieren","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B56","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/hmg\/ddp165","article-title":"Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks","volume":"18","author":"Song","year":"2009","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B57","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ki.2010.175","article-title":"Renal CD14 expression correlates with the progression of cystic kidney disease","volume":"78","author":"Zhou","year":"2010","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B58","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/j.ajkd.2010.06.023","article-title":"Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis","volume":"56","author":"Meijer","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000339440","article-title":"Early arterial stiffness and inflammatory bio-markers in normotensive polycystic kidney disease patients","volume":"36","author":"Kocyigit","year":"2012","journal-title":"Am J Nephrol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B60","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1681\/ASN.2011010084","article-title":"Macrophages promote cyst growth in polycystic kidney disease","volume":"22","author":"Karihaloo","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fimmu.2016.00008","article-title":"Macrophage migration inhibitory factor in clinical kidney disease","volume":"7","author":"Bruchfeld","year":"2016","journal-title":"Front Immunol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B62","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0700499104","article-title":"Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease","volume":"104","author":"Leuenroth","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B63","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1681\/ASN.2008030259","article-title":"Triptolide reduces cystogenesis in a model of ADPKD","volume":"19","author":"Leuenroth","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B64","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/ndt\/gfp777","article-title":"Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD","volume":"25","author":"Leuenroth","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B65","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.chembiol.2005.09.009","article-title":"Studies on calcium dependence reveal multiple modes of action for triptolide","volume":"12","author":"Leuenroth","year":"2005","journal-title":"Chem Biol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B66","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03104","article-title":"Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron","volume":"432","author":"Flo","year":"2004","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B67","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.kint.2016.09.005","article-title":"Overexpression of exogenous kidney-specific Ngal attenuates progressive cyst development and prolongs lifespan in a murine model of polycystic kidney disease","volume":"91","author":"Wang","year":"2017","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B68","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ki.2008.395","article-title":"Neutrophil gelatinase-associated lipocalin suppresses cyst growth by Pkd1 null cells in vitro and in vivo","volume":"74","author":"Wei","year":"2008","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B69","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2353\/ajpath.2009.090227","article-title":"Pkd2 dosage influences cellular repair responses following ischemia-reperfusion injury","volume":"175","author":"Prasad","year":"2009","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B70","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1681\/ASN.2008040435","article-title":"Pkd1 haploinsufficiency increases renal damage and induces microcyst formation following ischemia\/reperfusion","volume":"20","author":"Bastos","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B71","doi-asserted-by":"crossref","first-page":"H33","DOI":"10.1152\/ajpheart.01102.2011","article-title":"Pkd2 mesenteric vessels exhibit a primary defect in endothelium-dependent vasodilatation restored by rosiglitazone","volume":"304","author":"Brookes","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B72","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1681\/ASN.V134991","article-title":"Oxidant stress and reduced antioxidant enzyme protection in polycystic kidney disease","volume":"13","author":"Maser","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B73","doi-asserted-by":"crossref","first-page":"F1198","DOI":"10.1152\/ajprenal.00327.2014","article-title":"Endothelial dysfunction and oxidative stress in polycystic kidney disease","volume":"307","author":"Klawitter","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B74","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000355756","article-title":"Elevated asymmetric dimethylarginine is associated with oxidant stress aggravation in patients with early stage autosomal dominant polycystic kidney disease","volume":"38","author":"Raptis","year":"2013","journal-title":"Kidney Blood Press Res"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B75","doi-asserted-by":"crossref","first-page":"F763","DOI":"10.1152\/ajprenal.0337.2000","article-title":"Autocrine extracellular purinergic signaling in epithelial cells derived from polycystic kidneys","volume":"282","author":"Schwiebert","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B76","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000082247","article-title":"Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy\/+ rat, a model of autosomal dominant polycystic kidney disease","volume":"178","author":"Turner","year":"2004","journal-title":"Cells Tissues Organs"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B77","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fphys.2013.00218","article-title":"Role of extracellular ATP and P2 receptor signaling in regulating renal cyst growth and interstitial inflammation in polycystic kidney disease","volume":"4","author":"Rangan","year":"2013","journal-title":"Front Physiol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B78","doi-asserted-by":"crossref","first-page":"F15","DOI":"10.1152\/ajprenal.00103.2006","article-title":"Antagonism of endogenous putative P2Y receptors reduces the growth of MDCK-derived cysts cultured in vitro","volume":"292","author":"Turner","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B79","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1681\/ASN.2010070728","article-title":"Inhibition of the P2X7 receptor reduces cystogenesis in PKD","volume":"22","author":"Chang","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B80","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2215\/CJN.08350813","article-title":"Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease","volume":"9","author":"Cadnapaphornchai","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B81","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.2215\/CJN.11331114","article-title":"Pravastatin therapy and biomarker changes in children and young adults with autosomal dominant polycystic kidney disease","volume":"10","author":"Klawitter","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B82","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fped.2017.00053","article-title":"Clinical trials in pediatric autosomal dominant polycystic kidney disease","volume":"5","author":"Cadnapaphornchai","year":"2017","journal-title":"Front Pediatr"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B83","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.kint.2016.01.026","article-title":"Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease","volume":"90","author":"Cebotaru","year":"2016","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180801040003_gfx262-B84","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1172\/JCI64401","article-title":"Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease","volume":"123","author":"Zhou","year":"2013","journal-title":"J Clin Invest"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/33\/8\/1310\/25198337\/gfx262.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T19:31:02Z","timestamp":1719343862000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/33\/8\/1310\/4096832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,29]]},"references-count":84,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,29]]},"published-print":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfx262","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8]]},"published":{"date-parts":[[2017,8,29]]}}}